🇧🇷 Xofluza in Brazil

Xofluza (BALOXAVIR MARBOXIL) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Xofluza in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in Brazil

Frequently asked questions

Is Xofluza approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Xofluza in Brazil?

Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.